Antidiabetic adiponectin receptor agonist AdipoRon suppresses tumour growth of pancreatic cancer by inducing RIPK1/ERK-dependent necroptosis

Antidiabetic adiponectin receptor agonist AdipoRon suppresses tumour growth of pancreatic cancer by inducing RIPK1/ERK-dependent necroptosisAntidiabetic adiponectin receptor agonist AdipoRon suppresses tumour growth of pancreatic cancer by inducing RIPK1/ERK-dependent necroptosis, Published online: 23 July 2018; doi:10.1038/s41419-018-0851-zAntidiabetic adiponectin receptor agonist AdipoRon suppresses tumour growth of pancreatic cancer by inducing RIPK1/ERK-dependent necroptosis

Source: Cell death and disease - July 23, 2018 Category: Internal Medicine Authors: Miho Akimoto Riruke Maruyama Yasunari Kawabata Yoshitsugu Tajima Keizo Takenaga Source Type: research